Skip to main content

Table 1 Description of GSE datasets

From: Integrative bioinformatics analysis reveals miR-494 and its target genes as predictive biomarkers of trastuzumab-resistant breast cancer

Accession code

Sample

Number of samples

Type of RNA

References

GSE101841

Serum of tastuzumab-treated patients in China

61 sensitive to trastuzumab, 42 resistance to trastuzumab

miRNA

[20]

GSE75669

Breast tumor from Mexican patients treated with trastuzumab

4 samples from patient with complete response, 4 samples from patients with partial, progressives and poor response to trastuzumab

miRNA

[21]

GSE66305

Breast tumor from Italian patients treated with trastuzumab

5 samples from patients with complete response, and 18 patients with partial response to trastuzumab

mRNA

[22]